Correlation Between Innovator IBD and 446150AT1

Can any of the company-specific risk be diversified away by investing in both Innovator IBD and 446150AT1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovator IBD and 446150AT1 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Innovator IBD 50 and HBAN 5625, you can compare the effects of market volatilities on Innovator IBD and 446150AT1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovator IBD with a short position of 446150AT1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovator IBD and 446150AT1.

Diversification Opportunities for Innovator IBD and 446150AT1

-0.5

Correlation Coefficient

Innovator IBD  446150AT1

Very good diversification

The 3 months correlation between Innovator and 446150AT1 is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Innovator IBD 50 and HBAN 5625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HBAN 5625 and Innovator IBD is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovator IBD 50 are associated (or correlated) with 446150AT1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HBAN 5625 has no effect on the direction of Innovator IBD i.e., Innovator IBD and 446150AT1 go up and down completely randomly.

Pair Corralation between Innovator IBD and 446150AT1

Given the investment horizon of 90 days Innovator IBD 50 is expected to under-perform the 446150AT1. But the etf apears to be less risky and, when comparing its historical volatility, Innovator IBD 50 is 2.06 times less risky than 446150AT1. The etf trades about -0.13 of its potential returns per unit of risk. The HBAN 5625 is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  9,938  in HBAN 5625 on September 23, 2024 and sell it today you would lose (191.00) from holding HBAN 5625 or give up 1.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Innovator IBD 50  vs.  HBAN 5625

Innovator IBD 50

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Innovator IBD 50 are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Innovator IBD may actually be approaching a critical reversion point that can send shares even higher in January 2025.

HBAN 5625

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HBAN 5625 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 446150AT1 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Innovator IBD and 446150AT1

The main advantage of trading using opposite Innovator IBD and 446150AT1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovator IBD position performs unexpectedly, 446150AT1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 446150AT1 will offset losses from the drop in 446150AT1's long position.

The idea behind Innovator IBD 50 and HBAN 5625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.